These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 19470767)

  • 1. Abrogating drug resistance in malignant peripheral nerve sheath tumors by disrupting hyaluronan-CD44 interactions with small hyaluronan oligosaccharides.
    Slomiany MG; Dai L; Bomar PA; Knackstedt TJ; Kranc DA; Tolliver L; Maria BL; Toole BP
    Cancer Res; 2009 Jun; 69(12):4992-8. PubMed ID: 19470767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic imbalance of HMMR/RHAMM regulates the sensitivity and response of malignant peripheral nerve sheath tumour cells to aurora kinase inhibition.
    Mohan P; Castellsague J; Jiang J; Allen K; Chen H; Nemirovsky O; Spyra M; Hu K; Kluwe L; Pujana MA; Villanueva A; Mautner VF; Keats JJ; Dunn SE; Lazaro C; Maxwell CA
    Oncotarget; 2013 Jan; 4(1):80-93. PubMed ID: 23328114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor effects of 4-methylumbelliferone, a hyaluronan synthesis inhibitor, on malignant peripheral nerve sheath tumor.
    Ikuta K; Ota T; Zhuo L; Urakawa H; Kozawa E; Hamada S; Kimata K; Ishiguro N; Nishida Y
    Int J Cancer; 2017 Jan; 140(2):469-479. PubMed ID: 27706810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular-guided therapy predictions reveal drug resistance phenotypes and treatment alternatives in malignant peripheral nerve sheath tumors.
    Peacock JD; Cherba D; Kampfschulte K; Smith MK; Monks NR; Webb CP; Steensma M
    J Transl Med; 2013 Sep; 11():213. PubMed ID: 24040940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyaluronan, CD44, and emmprin regulate lactate efflux and membrane localization of monocarboxylate transporters in human breast carcinoma cells.
    Slomiany MG; Grass GD; Robertson AD; Yang XY; Maria BL; Beeson C; Toole BP
    Cancer Res; 2009 Feb; 69(4):1293-301. PubMed ID: 19176383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyaluronan oligosaccharides inhibit anchorage-independent growth of tumor cells by suppressing the phosphoinositide 3-kinase/Akt cell survival pathway.
    Ghatak S; Misra S; Toole BP
    J Biol Chem; 2002 Oct; 277(41):38013-20. PubMed ID: 12145277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyaluronan, CD44 and Emmprin: partners in cancer cell chemoresistance.
    Toole BP; Slomiany MG
    Drug Resist Updat; 2008 Jun; 11(3):110-21. PubMed ID: 18490190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular uptake and internalization of hyaluronan-based doxorubicin and cisplatin conjugates.
    Cai S; Alhowyan AA; Yang Q; Forrest WC; Shnayder Y; Forrest ML
    J Drug Target; 2014 Aug; 22(7):648-57. PubMed ID: 24892741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyaluronan bound to CD44 on keratinocytes is displaced by hyaluronan decasaccharides and not hexasaccharides.
    Tammi R; MacCallum D; Hascall VC; Pienimäki JP; Hyttinen M; Tammi M
    J Biol Chem; 1998 Oct; 273(44):28878-88. PubMed ID: 9786890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyaluronan-CD44 interaction with protein kinase C(epsilon) promotes oncogenic signaling by the stem cell marker Nanog and the Production of microRNA-21, leading to down-regulation of the tumor suppressor protein PDCD4, anti-apoptosis, and chemotherapy resistance in breast tumor cells.
    Bourguignon LY; Spevak CC; Wong G; Xia W; Gilad E
    J Biol Chem; 2009 Sep; 284(39):26533-46. PubMed ID: 19633292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD44 Contributes to the Regulation of MDR1 Protein and Doxorubicin Chemoresistance in Osteosarcoma.
    Gerardo-Ramírez M; Keggenhoff FL; Giam V; Becker D; Groth M; Hartmann N; Straub BK; Morrison H; Galle PR; Marquardt JU; Herrlich P; Hartmann M
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyaluronan expression as a significant prognostic factor in patients with malignant peripheral nerve sheath tumors.
    Ikuta K; Urakawa H; Kozawa E; Arai E; Zhuo L; Futamura N; Hamada S; Kimata K; Ishiguro N; Nishida Y
    Clin Exp Metastasis; 2014 Aug; 31(6):715-25. PubMed ID: 24957185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of MDR1 expression and drug resistance by a positive feedback loop involving hyaluronan, phosphoinositide 3-kinase, and ErbB2.
    Misra S; Ghatak S; Toole BP
    J Biol Chem; 2005 May; 280(21):20310-5. PubMed ID: 15784621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyaluronan: a constitutive regulator of chemoresistance and malignancy in cancer cells.
    Toole BP; Slomiany MG
    Semin Cancer Biol; 2008 Aug; 18(4):244-50. PubMed ID: 18534864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NF1 deficiency causes Bcl-xL upregulation in Schwann cells derived from neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors.
    Park HJ; Lee SJ; Sohn YB; Jin HS; Han JH; Kim YB; Yim H; Jeong SY
    Int J Oncol; 2013 Feb; 42(2):657-66. PubMed ID: 23292448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyaluronan-CD44 interaction promotes HPV 16 E6 oncogene-mediated oropharyngeal cell carcinoma survival and chemoresistance.
    Bourguignon LYW; Earle C; Shiina M
    Matrix Biol; 2019 May; 78-79():180-200. PubMed ID: 30077625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of tumor growth in vivo by hyaluronan oligomers.
    Zeng C; Toole BP; Kinney SD; Kuo JW; Stamenkovic I
    Int J Cancer; 1998 Jul; 77(3):396-401. PubMed ID: 9663602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD44-independent hepatocyte growth factor/c-Met autocrine loop promotes malignant peripheral nerve sheath tumor cell invasion in vitro.
    Su W; Gutmann DH; Perry A; Abounader R; Laterra J; Sherman LS
    Glia; 2004 Feb; 45(3):297-306. PubMed ID: 14730703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delivery of CD44 shRNA/nanoparticles within cancer cells: perturbation of hyaluronan/CD44v6 interactions and reduction in adenoma growth in Apc Min/+ MICE.
    Misra S; Hascall VC; De Giovanni C; Markwald RR; Ghatak S
    J Biol Chem; 2009 May; 284(18):12432-46. PubMed ID: 19246453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical therapeutic efficacy of a novel pharmacologic inducer of apoptosis in malignant peripheral nerve sheath tumors.
    Chau V; Lim SK; Mo W; Liu C; Patel AJ; McKay RM; Wei S; Posner BA; De Brabander JK; Williams NS; Parada LF; Le LQ
    Cancer Res; 2014 Jan; 74(2):586-97. PubMed ID: 24285727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.